BlackRock’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $615 | Sell |
60
-1,652
| -96% | -$16.9K | ﹤0.01% | 5300 |
|
|
2025
Q1 | $13.4K | Buy |
1,712
+416
| +32% | +$3.25K | ﹤0.01% | 5096 |
|
|
2024
Q4 | $21.1K | Sell |
1,296
-131
| -9% | -$2.13K | ﹤0.01% | 5037 |
|
|
2024
Q3 | $54.2K | Buy |
1,427
+52
| +4% | +$1.98K | ﹤0.01% | 4745 |
|
|
2024
Q2 | $61.9K | Buy |
1,375
+441
| +47% | +$19.8K | ﹤0.01% | 4763 |
|
|
2024
Q1 | $45.8K | Sell |
934
-2,222
| -70% | -$109K | ﹤0.01% | 4828 |
|
|
2023
Q4 | $242K | Buy |
3,156
+2,250
| +248% | +$172K | ﹤0.01% | 4514 |
|
|
2023
Q3 | $27.2K | Sell |
906
-38
| -4% | -$1.14K | ﹤0.01% | 5033 |
|
|
2023
Q2 | $50K | Buy |
944
+136
| +17% | +$7.21K | ﹤0.01% | 4979 |
|
|
2023
Q1 | $55.9K | Buy |
808
+26
| +3% | +$1.8K | ﹤0.01% | 5013 |
|
|
2022
Q4 | $62.2K | Buy |
782
+5
| +0.6% | +$398 | ﹤0.01% | 5085 |
|
|
2022
Q3 | $47K | Sell |
777
-22
| -3% | -$1.33K | ﹤0.01% | 5284 |
|
|
2022
Q2 | $61K | Sell |
799
-36
| -4% | -$2.75K | ﹤0.01% | 5279 |
|
|
2022
Q1 | $55K | Buy |
835
+501
| +150% | +$33K | ﹤0.01% | 5316 |
|
|
2021
Q4 | $29K | Buy |
334
+8
| +2% | +$695 | ﹤0.01% | 5424 |
|
|
2021
Q3 | $33K | Buy |
+326
| New | +$33K | ﹤0.01% | 5275 |
|